Hideyuki Tozaki
Director, Research & Development COO Oncology @ Eli Lilly and Company
About Hideyuki Tozaki
Hideyuki Tozaki serves as the Director of Research & Development COO Oncology at Eli Lilly and Company, where he has worked since 2018. He has extensive experience in clinical pharmacology and trial management, having held various positions at Eli Lilly since 1999.